Dr. Reddy’s Laboratories Ltd. reported its quarterly results for the period ended December 31, 2025, showing a revenue of U.S.$2,903 million and a profit of U.S.$448 million. This financial filing reflects significant growth and operations performance amidst various market challenges, indicating ongoing resilience in the company's strategy.